Relaxation Response Training to Treat Hypertension

NCT01263743 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2016-04-19

No results posted yet for this study

Summary

Interventions such as Relaxation Response appear to have widespread effects on physiology. Endothelial function, changes in genomic expression, several biomarkers have been associated with chronic stress and cardiovascular dysfunction, and there is some suggestion that elicitation of the Relaxation Response may lead to improvement in-or normalization of-these factors. By studying the impact of the Relaxation Response on endothelial function, genomic expression and biomarkers among subjects with hypertension, it may be possible to better understand the biologic underpinnings of Relaxation Response-type interventions. Furthermore, with a greater understanding of the physiologic mechanisms by which the Relaxation Response works, it may be possible to better target other symptoms and conditions that can be effectively treated by such an intervention.

Conditions

Interventions

BEHAVIORAL

Relaxation Response

The Relaxation Response is a type of relaxation. The goal of the Relaxation Response is to consciously elicit a reaction opposite in direction to the stress response.

BEHAVIORAL

Relaxation Response

Relaxation Response is a type of relaxation. This is a technique that elicits a state that is opposite to the stress response.

Sponsors & Collaborators

  • Brigham and Women's Hospital

    collaborator OTHER
  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Jeffrey Huffman, MD · Massachusetts General Hospital

  • Randall Zusman, MD · Massachusetts General Hospital

  • Mark A Creager, MD · Brigham and Women's Hospital

  • John W Denninger, MD · Massachusetts General Hospital

  • Herbert Benson, MD · Massachusetts General Hospital

  • Gregory Fricchione, MD · Massachusetts General Hospital

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01263743 on ClinicalTrials.gov